Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Arcus Biosciences (RCUS) Interest & Investment Income: 2017-2024

Historic Interest & Investment Income for Arcus Biosciences (RCUS) over the last 8 years, with Dec 2024 value amounting to $52.0 million.

  • Arcus Biosciences' Interest & Investment Income fell 28.57% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.0 million, marking a year-over-year decrease of 15.69%. This contributed to the annual value of $52.0 million for FY2024, which is 26.83% up from last year.
  • According to the latest figures from FY2024, Arcus Biosciences' Interest & Investment Income is $52.0 million, which was up 26.83% from $41.0 million recorded in FY2023.
  • Arcus Biosciences' Interest & Investment Income's 5-year high stood at $52.0 million during FY2024, with a 5-year trough of $1.0 million in FY2020.
  • Its 3-year average for Interest & Investment Income is $36.3 million, with a median of $41.0 million in 2023.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first slumped by 80.77% in 2020, then skyrocketed by 1,500.00% in 2022.
  • Arcus Biosciences' Interest & Investment Income (Yearly) stood at $1.0 million in 2020, then remained steady at $1.0 million in 2021, then surged by 1,500.00% to $16.0 million in 2022, then surged by 156.25% to $41.0 million in 2023, then increased by 26.83% to $52.0 million in 2024.